The Latest “Buzz on the Street” Show: Featuring Weekend Unlimited (CSE: POT) (OTCQB: WKULF) Coverage’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Weekend Unlimited Completes Acquisition Of Jamaican Assets”, “Northern Lights Supply Store in Alberta Receives First Inventory in Preparation for Grand Opening” and “OTC Markets Group Welcomes New OTCQB Companies”

Weekend Unlimited Inc.(CSE: POT) (OTCQB: WKULF) having announced the signing of a definitive agreement on 13 February 2019 to acquire R&D Pharma’s Jamaican interests, has completed the arms-length acquisition of R&D Pharma.

Weekend Unlimited Inc. is pleased to announce that Northern Lights Supply in Nisku, Alberta has received its initial shipment from AGLC allowing it to set a grand opening date for February 23rd.

OTC Markets Group Inc., operator of financial markets for 10,000 U.S. and global securities, today announced Weekend Unlimited is approved for trading on the OTCQB Venture Market.

Weekend Unlimited is capitalizing on its vast industry relationships to establish a lifestyle brand featuring premium products and delivering life’s highest moments. The company aggregates and scales small to medium brands, primarily in the categories of flower, extracts and edibles.

Marijuana has become a global medical phenomenon due to its therapeutic effects. Primarily, many countries are looking to legalize marijuana for medical applications as it is a suitable alternative to opioids. However, one of marijuana’s derivatives, hemp, is becoming widely adopted, particularly in the U.S. Hemp has gained significant popularity among state officials and consumers after the passage of the recent U.S. Farm Bill. Even with the passage of the bill, hemp itself is still not entirely legalized, but it’s derivative CBD, or cannabidiol, is fully legalized in almost every state. Hemp-derived CBD products are generally more accepted because they are the non-psychoactive cannabis-related products. Due to its therapeutic and relaxing effects, the U.S. Food and Drug Administration formally delisted CBD from the list of Schedule 1 drugs last year. In combination with the FDA’s decision and the passage of the Farm Bill, the CBD market is positioned for tremendous growth. According to data compiled by Brightfield Group, the U.S. CBD market is expected to reach USD 22 Billion by 2022, outpacing the rest of the cannabis market combined. 

CBD has many versatile uses such as medical applications, health and wellness, beauty, and even pet treats. CBD also comes in many forms such as flowers, oils, creams, and tinctures. As the CBD industry continues to grow, new products like beverages and foods are emerging. Within medical applications, consumers are using CBD to treat conditions such as insomnia, pain, and anxiety. Recreationally, consumers are simply using CBD as a relaxation stimulant. “A few years ago almost no one knew what hemp-derived CBD was, it was sold by mostly small brands of tinctures online and through head shops. All of a sudden, CBD is everywhere – it is both a trendy, new ingredient in drinks, face creams and pet treats and an answer to the prayers of so many people suffering from medical conditions ranging from epilepsy to anxiety and chronic pain. It rides the waves of so many global food and health trends, as a substitute for opioids, towards more natural health alternatives and functional ingredients,” said Bethany Gomez, Managing Director at Brightfield Group.

For more information, please visit: Weekend Unlimited Inc.

For more corporate news on WeedMD Inc., check out the Buzz on the Street

About Buzz on the Street: One of’s latest corporate and financial news shows, covering the latest trending stock market news. Buzz on the Street looks to become a leader in corporate video news dissemination. Buzz on the Street is 100% original content, brought to you by Financial Buzz Media.

Sponsored Content Release. Click for Full Disclosure

  1. Ginelys Velez 4 months ago

    I feel so sorry for people who don’t have access to medical cannabis, it truly enriches your world.. mentality and physically. Go and explore the mystical world of #thc #cbd #cannabis #weedoil #mmj #wietolie #CB1 #CB2 #cancer #epileptic #opiatreplcement #AIDS #copd #apneu

    • Mark Mandell 4 months ago

      Do you have to disclose medical cannabis use at job interviews? Does that play a role in the hiring process?

  2. Julien B. 4 months ago

    The Cannabis Licensing Authority (CLA) has issued 29 licences to 23 people since the authority’s inception. More to come

Leave a Comment

    • Sponsored Content Release, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, creates 100% unique original content. also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

      Please Note: is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on (the ‘Site’) is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content),, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. receives fees for producing and presenting high quality and sophisticated content on along with other financial news PR media services. does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For weekend unlimited inc., financial and corporate news dissemination, expects to be compensated five thousand dollars by the company. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. will always disclose any compensation in securities or cash payments for financial news PR advertising. does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security., members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: